Literature DB >> 25867746

Use of a new acellular dermal matrix for treatment of nonhealing wounds in the lower extremities of patients with diabetes.

Layne Yonehiro1, Glenn Burleson2, Victoria Sauer2.   

Abstract

INTRODUCTION: Acellular dermal matrices (ADMs) have successfully been used in the treatment of nonhealing wounds in patients with diabetes.
METHODS: A new decellularized biological scaffold derived from human skin, D-ADM, (DermACELL, LifeNet Health, Virginia Beach, VA), has shown increased cell infiltration, host tissue integration, and vascularization in comparison to other ADMs. This clinical investigation evaluated the wound closing properties of D-ADM on 18 full-thickness lower extremity wounds in 15 patients with diabetes over a period of 12 weeks.
RESULTS: A complete wound closure (100% epithelialization) rate of 58% (7/12) and an average duration of 10 weeks was demonstrated. Wound healing, defined as ≥ 95% wound closure, was established in 83% of the wounds (10/12) by the end of the study treatment.
CONCLUSION: These results compare favorably with other methods of advanced wound care treatment options that utilize skin substitutes to accelerate the healing of difficult-to-treat or chronic wounds.

Entities:  

Year:  2013        PMID: 25867746

Source DB:  PubMed          Journal:  Wounds        ISSN: 1044-7946            Impact factor:   1.546


  13 in total

1.  Use of a novel acellular dermal matrix allograft to treat complex trauma wound: a case study.

Authors:  Sima B Shitrit; Yitzchak Ramon; Giampietro Bertasi
Journal:  Int J Burns Trauma       Date:  2014-10-26

2.  Novel use of an acellular dermal matrix allograft to treat a chronic scalp wound with bone exposure: a case study.

Authors:  John L Roussalis
Journal:  Int J Burns Trauma       Date:  2014-10-26

Review 3.  An overview of the therapeutic potential of regenerative medicine in cutaneous wound healing.

Authors:  Calver Pang; Amel Ibrahim; Neil W Bulstrode; Patrizia Ferretti
Journal:  Int Wound J       Date:  2017-03-06       Impact factor: 3.315

Review 4.  Effect of Topical Administration of Fractions and Isolated Molecules from Plant Extracts on Skin Wound Healing: A Systematic Review of Murine Experimental Models.

Authors:  Mariáurea Matias Sarandy; Fernanda Barbosa Lopes; Sérgio Luis Pinto da Matta; Marcus Vinicius Mello Pinto; Sirlene Souza Rodrigues Sartori; Rômulo Dias Novaes; Reggiani Vilela Golçalves
Journal:  Mediators Inflamm       Date:  2016-10-17       Impact factor: 4.711

Review 5.  Tissue specific microenvironments: a key tool for tissue engineering and regenerative medicine.

Authors:  Patrick C Sachs; Peter A Mollica; Robert D Bruno
Journal:  J Biol Eng       Date:  2017-11-16       Impact factor: 4.355

Review 6.  Decellularization of human dermis using non-denaturing anionic detergent and endonuclease: a review.

Authors:  Mark A Moore; Brian Samsell; Glenna Wallis; Sherry Triplett; Silvia Chen; Alyce Linthurst Jones; Xiaofei Qin
Journal:  Cell Tissue Bank       Date:  2014-08-28       Impact factor: 1.522

Review 7.  Challenges in the Treatment of Chronic Wounds.

Authors:  Robert G Frykberg; Jaminelli Banks
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-09-01       Impact factor: 4.730

8.  Healing Rates in a Multicenter Assessment of a Sterile, Room Temperature, Acellular Dermal Matrix Versus Conventional Care Wound Management and an Active Comparator in the Treatment of Full-Thickness Diabetic Foot Ulcers.

Authors:  Jodi Walters; Shawn Cazzell; Hau Pham; Dean Vayser; Alexander Reyzelman
Journal:  Eplasty       Date:  2016-02-04

Review 9.  Engineered Biopolymeric Scaffolds for Chronic Wound Healing.

Authors:  Laura E Dickinson; Sharon Gerecht
Journal:  Front Physiol       Date:  2016-08-05       Impact factor: 4.566

Review 10.  Implications of Extracellular Matrix Production by Adipose Tissue-Derived Stem Cells for Development of Wound Healing Therapies.

Authors:  Kathrine Hyldig; Simone Riis; Cristian Pablo Pennisi; Vladimir Zachar; Trine Fink
Journal:  Int J Mol Sci       Date:  2017-05-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.